Literature DB >> 18242791

Comparative studies on in vitro expression and in vivo immunogenicity of supercoiled and open circular forms of plasmid DNA vaccines.

Vinod Bhaskara Pillai1, Michael Hellerstein, Tianwei Yu, Rama Rao Amara, Harriet L Robinson.   

Abstract

Here we use tests for in vitro expression and in vivo immunogenicty to compare the biological activity of supercoiled and open circular forms of plasmid DNA vaccines. The different forms of vaccine DNA revealed no differences in the expression of mRNA or protein following DEAE-dextran-assisted transfection of cultured cells. In contrast, following intramuscular saline injections in mice, supercoiled DNA was three times more effective than open circular DNA at priming a MVA-boosted CD8 T cell response. Thus, under our experimental conditions, measurements for supercoiled vaccine DNA provided a more accurate assessment of the potential to prime a CD8 response than tests for expression in transiently transfected cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18242791      PMCID: PMC2692637          DOI: 10.1016/j.vaccine.2007.10.023

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

Review 1.  Induction of CD8+ T cells using heterologous prime-boost immunisation strategies.

Authors:  J Schneider; S C Gilbert; C M Hannan; P Dégano; E Prieur; E G Sheu; M Plebanski; A V Hill
Journal:  Immunol Rev       Date:  1999-08       Impact factor: 12.988

2.  Gene transfer in vitro and in vivo by cationic lipids is not significantly affected by levels of supercoiling of a reporter plasmid.

Authors:  D Bergan; T Galbraith; D L Sloane
Journal:  Pharm Res       Date:  2000-08       Impact factor: 4.200

3.  Rapid analysis of a plasmid by hydrophobic-interaction chromatography with a non-porous resin.

Authors:  S Iuliano; J R Fisher; M Chen; W J Kelly
Journal:  J Chromatogr A       Date:  2002-09-27       Impact factor: 4.759

4.  Effective and robust plasmid topology analysis and the subsequent characterization of the plasmid isoforms thereby observed.

Authors:  Michael J Molloy; Valerie S Hall; Susannah I Bailey; Katharine J Griffin; Jim Faulkner; Mark Uden
Journal:  Nucleic Acids Res       Date:  2004-09-09       Impact factor: 16.971

5.  Impact of plasmid supercoiling on the efficacy of a rabies DNA vaccine to protect cats.

Authors:  Lionel Cupillard; Véronique Juillard; Sophie Latour; Guy Colombet; N Cachet; S Richard; S Blanchard; Laurent Fischer
Journal:  Vaccine       Date:  2005-03-14       Impact factor: 3.641

6.  Improved downstream process for the production of plasmid DNA for gene therapy.

Authors:  Jochen Urthaler; Wolfgang Buchinger; Roman Necina
Journal:  Acta Biochim Pol       Date:  2005       Impact factor: 2.149

7.  Dose-response studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boost.

Authors:  Jinyan Liu; Michael Hellerstein; Michael McDonnel; Rama Rao Amara; Linda S Wyatt; Bernard Moss; Harriet L Robinson
Journal:  Vaccine       Date:  2006-06-09       Impact factor: 3.641

8.  Immunogenicity in macaques of the clinical product for a clade B DNA/MVA HIV vaccine: elicitation of IFN-gamma, IL-2, and TNF-alpha coproducing CD4 and CD8 T cells.

Authors:  Harriet L Robinson; Sunita Sharma; Jun Zhao; Sunil Kannanganat; Lilin Lai; Lakshmi Chennareddi; Tianwei Yu; David C Montefiori; Rama Rao Amara; Linda S Wyatt; Bernard Moss
Journal:  AIDS Res Hum Retroviruses       Date:  2007-12       Impact factor: 2.205

9.  DNA/MVA vaccine for HIV type 1: effects of codon-optimization and the expression of aggregates or virus-like particles on the immunogenicity of the DNA prime.

Authors:  James M Smith; Rama Rao Amara; David Campbell; Yan Xu; Milloni Patel; Sunita Sharma; Salvatore T Butera; Dennis L Ellenberger; Hong Yi; Lakshmi Chennareddi; James G Herndon; Linda S Wyatt; David Montefiori; Bernard Moss; Harold M McClure; Harriet L Robinson
Journal:  AIDS Res Hum Retroviruses       Date:  2004-12       Impact factor: 2.205

10.  Evaluation of degradation pathways for plasmid DNA in pharmaceutical formulations via accelerated stability studies.

Authors:  R K Evans; Z Xu; K E Bohannon; B Wang; M W Bruner; D B Volkin
Journal:  J Pharm Sci       Date:  2000-01       Impact factor: 3.534

View more
  6 in total

1.  Separation of supercoiled from open circular forms of plasmid DNA, and biological activity detection.

Authors:  Huangjin Li; Huaben Bo; Jinquan Wang; Hongwei Shao; Shulin Huang
Journal:  Cytotechnology       Date:  2010-12-01       Impact factor: 2.058

Review 2.  Vaccine design for CD8 T lymphocyte responses.

Authors:  Richard A Koup; Daniel C Douek
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

3.  A cell engineering strategy to enhance supercoiled plasmid DNA production for gene therapy.

Authors:  Sally Hassan; Eli Keshavarz-Moore; John Ward
Journal:  Biotechnol Bioeng       Date:  2016-03-16       Impact factor: 4.530

Review 4.  DNA/MVA Vaccines for HIV/AIDS.

Authors:  Smita S Iyer; Rama R Amara
Journal:  Vaccines (Basel)       Date:  2014-02-28

5.  A mouse strain defective in both T cells and NK cells has enhanced sensitivity to tumor induction by plasmid DNA expressing both activated H-Ras and c-Myc.

Authors:  Li Sheng-Fowler; Wei Tu; Haiqing Fu; Haruhiko Murata; Lynda Lanning; Gideon Foseh; Juliete Macauley; Donald Blair; Stephen H Hughes; John M Coffin; Andrew M Lewis; Keith Peden
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

6.  Accurate quantification of supercoiled DNA by digital PCR.

Authors:  Lianhua Dong; Hee-Bong Yoo; Jing Wang; Sang-Ryoul Park
Journal:  Sci Rep       Date:  2016-04-11       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.